This website is intended for healthcare professionals only.

Newsletter      
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Oncology

Genmab announces European regulatory submission for ofatumumab for relapsed CLL
Genmab announces European regulatory submission for ofatumumab for relapsed CLL
Planmed launches the new Planmed Clarity™ 3D system
Planmed launches the new Planmed Clarity™ 3D system
Proton Partners International acquires site for first Proton Beam Therapy cancer treatment centre
Proton Partners International acquires site for first proton beam therapy cancer treatment centre
Bristol-Myers Squibb will win big with melanoma combination immunotherapy
Bristol-Myers Squibb will win big with melanoma combination immunotherapy
New digital pathology network aims to transform diagnosis and treatment of cancer and other diseases
Digital pathology network aims to transform diagnosis and treatment of cancer and other diseases
New screening technique could pick up twice as many women with ovarian cancer
Screening technique could pick up twice as many women with ovarian cancer
First new treatment authorised in a decade for advanced cervical cancer patients in the UK
First new treatment authorised in a decade for advanced cervical cancer patients in the UK
Be Clear on Cancer Oesophago-gastric early diagnosis campaign launches
Be Clear on Cancer Oesophago-gastric early diagnosis campaign launches
Orphan medicine
Orphan medicine, Ramucirumab (Cyramza®), provides long-awaited advance for difficult to treat stomach cancer
New Oncology to collaborate with NCCS on genetic testing
New Oncology to collaborate with NCCS on genetic testing
Almac announces launch of CLIA validated next generation sequencing assay for p53 mutations
Almac announces launch of CLIA validated next generation sequencing assay for p53 mutations
Most people unaware that women with high breast density are more likely to develop breast cancer
Most people unaware that women with high breast density are more likely to develop breast cancer


Popular articles

Aspirin use associated with improved survival but only for bladder and breast cancer
Metformin use in diabetes protective against COVID-19-related mortality
Low levels of alcohol intake linked to greater risk of atrial fibrillation
Bimagrumab leads to significant fat loss in obese, type 2 diabetic patients
Higher convalescent plasma antibody titre levels associated with lower risk of death in COVID-19




 
Hospital Healthcare Europe
 
LinkedIn Logo Footer  Twitter Logo Footer

Ⓒ Cogora 2021
Cogora Limited, 140 London Wall, London EC2Y 5DN, Registered in the United Kingdom. Reg. No. 2147432

Hospital Healthcare Europe
HOPE Logo Footer